Literature DB >> 26237247

Taming Cell Penetrating Peptides: Never Too Old To Teach Old Dogs New Tricks.

Qianyu Zhang1, Huile Gao1, Qin He1.   

Abstract

Cell penetrating peptides (CPPs) have received substantial attention due to their intrinsic property to cross plasma membranes or even as helpers to facilitate the cellular entry of drug molecules, macromolecules, and nanoparticles. Although CPPs and CPP-like peptides provided versatile platforms for drug delivery, their nonselectivity or lack of delivery efficiency is stirring up debates as to the tactics for the optimizing the CPPs themselves. The good news is that, as spurred by the recent progress in the understanding of tumor microenvironment as well as biochemistry and material sciences, we have made attempts in working on perfecting or even "taming" CPPs and CPP-functionalized drug vectors for tumor delivery, and some of them afforded gratifying results. Due to the fact that these peptides are mainly short peptides made up of amino acids (5-30 amino acids), the addition, modification, or replacement of amino acids might lead to surprisingly improved performance. Several novel environment-responsive CPPs or CPP-like peptides have also been discovered. In this review we will discuss the measures taken to harness the power of CPPs and the discovery of environment-responsive peptides with CPP properties.

Entities:  

Keywords:  cell penetrating peptides (CPPs); drug delivery systems; improved efficiency; responsive; selectivity

Mesh:

Substances:

Year:  2015        PMID: 26237247     DOI: 10.1021/acs.molpharmaceut.5b00428

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  5 in total

1.  Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.

Authors:  Bai Xiang; Xue-Li Jia; Jin-Long Qi; Li-Ping Yang; Wei-Hong Sun; Xiao Yan; Shao-Kun Yang; De-Ying Cao; Qing Du; Xian-Rong Qi
Journal:  Int J Nanomedicine       Date:  2017-03-28

2.  Intracellular Delivery of DNA and Protein by a Novel Cell-Permeable Peptide Derived from DOT1L.

Authors:  Jingping Geng; Xiangli Guo; Lidan Wang; Richard Q Nguyen; Fengqin Wang; Changbai Liu; Hu Wang
Journal:  Biomolecules       Date:  2020-02-02

3.  Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell-Penetrative MMP-2-Cleavable Peptide.

Authors:  Dan Hua; Lida Tang; Weiting Wang; Shengan Tang; Lin Yu; Xuexia Zhou; Qian Wang; Cuiyun Sun; Cuijuan Shi; Wenjun Luo; Zhendong Jiang; Huining Li; Shizhu Yu
Journal:  Adv Sci (Weinh)       Date:  2020-12-21       Impact factor: 16.806

4.  Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy.

Authors:  Ting Zhao; Ce Liang; Yanrong Zhao; Xiangdong Xue; Zhao Ma; Jinlong Qi; Haitao Shen; Shaokun Yang; Jia Zhang; Qingzhong Jia; Qing Du; Deying Cao; Bai Xiang; Hailin Zhang; Xianrong Qi
Journal:  J Nanobiotechnology       Date:  2022-04-02       Impact factor: 10.435

5.  Oligohistidine and targeting peptide functionalized TAT-NLS for enhancing cellular uptake and promoting angiogenesis in vivo.

Authors:  Qian Li; Xuefang Hao; Syed Saqib Ali Zaidi; Jintang Guo; Xiangkui Ren; Changcan Shi; Wencheng Zhang; Yakai Feng
Journal:  J Nanobiotechnology       Date:  2018-03-26       Impact factor: 10.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.